Ybañez, Ruben D.

HRN: 23-88-89  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/13/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
10/13/2023
10/19/2023
IVTT
4.5g
Q8
Cap HR
Waiting Final Action 
10/13/2023
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
10/13/2023
10/26/2023
IVTT
750 Mg
Ivtt
Cap HR ; PTB
Waiting Final Action 
10/22/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
10/19/2023
11/09/2023
IV INFUSION
4.5g
Q8H
Continue For 7 Days More; CAP HR PTB
Waiting Final Action 
10/30/2023
NYSTATIN 100,000IU/ML, 30ML SUSPENSION (BOT)
10/30/2023
11/06/2023
ORAL
3ml
TID
Oral Candidiasis
Waiting Final Action 
11/10/2023
NYSTATIN 100,000IU/ML, 30ML SUSPENSION (BOT)
11/10/2023
11/16/2023
ORAL
3ml
TID
Oral Candidiasis
Waiting Final Action 
11/13/2023
CEFTRIAXONE 1G (VIAL)
11/13/2023
11/20/2023
IV
2g
OD
Complicated UTI
Waiting Final Action 
11/15/2023
CEFTRIAXONE 1G (VIAL)
11/15/2023
11/22/2023
IV
1g
Q8
Complicated UTI CAP HR
Waiting Final Action 
11/22/2023
CEFTAZIDIME 1GM (VIAL)
11/22/2023
11/24/2023
IV
1g
Q8H
CAP HR
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: